Scholar Rock Holding (SRRK) Cash & Equivalents (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.08% |
| Dec 31, 2025 | 12.82% |
| Sep 30, 2025 | 87.52% |
| Jun 30, 2025 | 10.87% |
| Mar 31, 2025 | -22.46% |
| Dec 31, 2024 | 132.85% |
| Sep 30, 2024 | -18.19% |
| Jun 30, 2024 | 1.51% |
| Mar 31, 2024 | -9.70% |
| Dec 31, 2023 | 50.68% |
| Sep 30, 2023 | -37.45% |
| Jun 30, 2023 | -28.57% |
| Mar 31, 2023 | 46.48% |
| Dec 31, 2022 | -22.39% |
| Sep 30, 2022 | -56.47% |
| Jun 30, 2022 | 205.20% |
| Mar 31, 2022 | -52.93% |
| Dec 31, 2021 | 20.84% |
| Sep 30, 2021 | -14.88% |
| Jun 30, 2021 | 30.05% |
| Mar 31, 2021 | -0.78% |
| Dec 31, 2020 | 185.20% |
| Sep 30, 2020 | -51.16% |
| Jun 30, 2020 | 20.64% |
| Mar 31, 2020 | 162.85% |
| Dec 31, 2019 | 11.23% |
| Sep 30, 2019 | -71.32% |
| Jun 30, 2019 | 69.84% |
| Mar 31, 2019 | -41.77% |
| Dec 31, 2018 | 10.66% |
| Sep 30, 2018 | -9.63% |